Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

Synopsis

"Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, swot analysis, business description, company history, key competitors, financial analysis, key employees, company locations and subsidiaries as well as employee biographies.

Summary

This report is a crucial resource for industry executives and anyone looking to access key information about "Daiichi Sankyo Company, Ltd".

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about "Daiichi Sankyo Company, Ltd" for business intelligence requirements.
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
• Provides data on company financial performance.
• The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.

Reasons To Buy

• Quickly enhance your understanding of "Daiichi Sankyo Company, Ltd"
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’ businesses better.
• Recognize potential partnerships and suppliers.

Key Highlights

Daiichi Sankyo Company, Ltd (Daiichi Sankyo) is a holding company, based in Japan. The company is focused on research, development, manufacture and marketing of pharmaceutical products. The company's business operations are classified into two divisions: Pharmaceuticals and Others. The company's Pharmaceuticals division manufactures and markets prescription drug, over-the-counter (OTC) drugs and quasidrugs. Under Others division, the company is involved in the real estate leasing, insurance agency business, and provision for human affairs and accounting services. The pharmaceutical products of the company are targeted at treating hypertension, hyperlipidemia, diabetes, heart failure, arrhythmia and heart attack. It also offers functional foods and skin care products. Outside Japan, Daiichi Sankyo has presence in the Americas, Europe, and other Asian countries. In Japan, the company has six production plants, three R&D bases, and 16 branches. It has ten group companies in Japan that handle different areas of business. Daiichi Sankyo has 107 subsidiaries and three affiliates. The company is headquartered in Tokyo, Japan.

Table of Contents

1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset and Liabilities
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Operational Efficiency
2.2.5 Solvency
2.2.6 Valuation
2.3 Key Competitors
3 SWOT Analysis
3.1 SWOT Analysis - Overview
3.2 Strengths
3.3 Weaknesses
3.4 Opportunities
3.5 Threats
4 History
5 Key Employees
6 Key Employee Biographies
7 Locations and Subsidiaries
7.1 Head Office
7.2 Other Locations and Subsidiaries
8 Appendix
8.1 Methodology
8.2 Ratio Definitions
8.3 Disclaimer

List of Tables

Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries

List of Figures

Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Operational Efficiency
Figure 5: Solvency
Figure 6: Valuation